Related Experiment Video
Updated: May 14, 2026

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
[Triptans in clinical practice: effectiveness, tolerance and patient's satisfaction with medication (TRIPRACLI
J M Lainez-Andres1, A Caminero, S Diaz-Insa
1Servicios de Neurología, Hospital Clínico Universitario, Universidad Católica de Valencia, Espana. jlaineza@meditex.es
Patients with migraine report high satisfaction with triptans, with no significant differences in effectiveness among them. This study found no predictive factors for choosing specific triptans based on migraine attack characteristics.
Area of Science:
- Neurology
- Pharmacology
Context:
- Migraine treatment remains a significant challenge, with triptans being a cornerstone therapy.
- Patient-reported outcomes and satisfaction are crucial in evaluating migraine medications.
Purpose:
- To assess the effectiveness, tolerance, and satisfaction of different triptans in migraine patients.
- To develop a predictive model for recommending triptans based on migraine attack characteristics.
Summary:
- A retrospective study of 160 migraine patients using eletriptan, almotriptan, or rizatriptan found high patient and physician satisfaction (88% and 65%).
- All triptans showed high effectiveness (VAS > 7), with no statistically significant differences based on attack characteristics.
- Patients preferred their current triptan over previous ones or non-specific drugs, suggesting perceived efficacy despite a lack of predictive factors.
Impact:
- Triptans are a well-tolerated and highly satisfactory treatment option for migraine patients.
- Current evidence does not support predicting specific triptan use based on migraine attack features.
- Further research may explore individual patient factors influencing triptan response and preference.
Related Concept Videos
Clinical Trials: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Clinical Trials
There are four phases in a clinical trial. A phase one...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drug Therapy
Antianxiety Medications
Therapeutic Drug Monitoring: Affecting Factors
